Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Amgen inc. source : Www.globenewswire.com save search
Opthea Appoints John Han, PharmD, as VP Medical Affairs
Published: 2024-04-08 (Crawled : 23:00) - globenewswire.com
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: 0.31%
H: 0.83%
C: 0.27%
OPT | $3.41 0.29% 0.29% 2.7K
|
Health Technology
|
| O: -2.73%
H: 3.57%
C: 3.32%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.37%
H: 0.38%
C: 0.06%
ADVM | $11.135 -1.89% -1.93% 100K
|
Health Technology
|
| O: -0.4%
H: 1.52%
C: -4.15%
medical
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: -1.58%
H: 1.87%
C: 0.53%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: -1.86%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.58%
H: 1.2%
C: 0.84%
business year update financial results
Sandoz receives FDA approval for first and only denosumab biosimilars
Published: 2024-03-05 (Crawled : 19:00) - globenewswire.com
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.46%
H: 1.3%
C: 0.44%
fda first approval
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
Published: 2024-02-08 (Crawled : 11:00) - globenewswire.com
ZYME | $8.68 -1.92% -1.96% 730K
|
Health Technology
|
| O: 0.26%
H: 2.42%
C: 0.97%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -31.6%
H: 410.14%
C: 110.51%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.27%
H: 0.27%
C: 0.17%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -1.87%
H: 0.61%
C: -1.46%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.38%
H: 0.34%
C: -0.72%
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Published: 2024-01-29 (Crawled : 09:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: 2.39%
H: 4.67%
C: 1.67%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: -1.05%
H: 0.41%
C: -0.35%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.11%
H: 0.7%
C: 0.65%
avt03 prolia biosimilar positive results study
SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
SWTX | News | $42.48 -3.7% -3.84% 810K
|
Health Technology
|
| O: -1.58%
H: 11.22%
C: 11.16%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.36%
H: 3.65%
C: 3.35%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.5%
H: 3.18%
C: 3.12%
conference therapeutics
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
Published: 2024-01-04 (Crawled : 13:00) - globenewswire.com
THRD | $11.47 1.68% 1.66% 200K
|
|
| O: 1.59%
H: 3.13%
C: 2.4%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.27%
H: 1.19%
C: 0.55%
business update financial
SpringWorks Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-11-02 (Crawled : 11:00) - globenewswire.com
SWTX | News | $42.48 -3.7% -3.84% 810K
|
Health Technology
|
| O: 4.14%
H: 6.22%
C: 1.41%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.5%
H: 2.69%
C: -0.09%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.94%
H: 1.82%
C: 1.25%
business therapeutics financial results
HP Inc. Names David Meline to Board of Directors
Published: 2023-09-21 (Crawled : 12:30) - globenewswire.com
ABBNY | News | $45.795 4.05% 170K
|
n/a
|
| O: -0.99%
H: 0.5%
C: -0.17%
ABLZF | News | $45.744 -32.74% 1.5K
|
Producer Manufacturing
|
| O: -1.68%
H: 0.02%
C: 0.02%
HPQ | $27.62 -0.25% 0.07% 4.5M
|
Electronic Technology
|
| O: 0.0%
H: 0.67%
C: -0.96%
GM | News 0 d | $42.44 -0.05% 0.0% 14M
|
Consumer Durables
|
| O: -0.87%
H: 1.6%
C: -0.61%
MMM | $91.48 0.57% 0.0% 3M
|
Producer Manufacturing
|
| O: -0.44%
H: 0.68%
C: -1.08%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.22%
H: 0.15%
C: -0.98%
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update
Published: 2023-08-30 (Crawled : 20:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: 0.21%
H: 3.28%
C: 1.54%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -1.03%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: 1.24%
H: 1.23%
C: 0.88%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.13%
H: 0.3%
C: -0.73%
six business update financial results
Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress
Published: 2023-08-08 (Crawled : 20:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: 0.0%
RVMD S | $35.81 -2.74% -2.82% 1M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
update financial results
Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires
Published: 2023-07-20 (Crawled : 21:00) - globenewswire.com
GNLX | $3.9 7.88% 7.31% 110K
|
|
| O: 0.21%
H: 1.07%
C: -15.94%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.23%
H: 1.12%
C: 0.45%
management corporation
Nasdaq Welcomed 60 IPOs in the First Half of 2023
Published: 2023-06-28 (Crawled : 11:00) - globenewswire.com
WDFC P | $230.17 -0.19% -0.2% 110K
|
Process Industries
|
| O: 0.02%
H: 0.0%
C: -0.55%
NDAQ | $60.075 0.11% 0.11% 2.3M
|
Finance
|
| O: 0.06%
H: 0.37%
C: -0.54%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.17%
H: 0.05%
C: -0.42%
AGNC | $9.07 0.33% 0.33% 13M
|
Finance
|
| O: 0.1%
H: 0.34%
C: 0.19%
Longeveron Welcomes Three New Prominent Board Members
Published: 2023-06-13 (Crawled : 12:20) - globenewswire.com
LGVN | News P 0 d | $2.005 -4.07% -4.24% 990K
|
|
| O: 2.46%
H: 2.93%
C: 0.8%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.37%
H: 0.84%
C: 0.46%
PCSA M | $1.56 -6.02% -6.41% 63K
|
Producer Manufacturing
|
| O: 4.95%
H: 0.0%
C: -9.91%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.03%
H: 2.26%
C: 2.1%
Sandoz Marketing Authorization Applications for proposed biosimilar denosumab accepted by EMA
Published: 2023-05-25 (Crawled : 06:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -0.89%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.55%
H: 0.0%
C: -1.2%
biosimilar authorization ema
Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update
Published: 2023-05-19 (Crawled : 09:00) - globenewswire.com
ALVO | $12.9 0.78% 0.78% 90K
|
n/a
|
| O: 8.94%
H: 0.0%
C: -7.65%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.36%
H: 1.01%
C: 0.82%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.29%
H: 1.35%
C: 0.87%
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: 0.64%
H: 1.56%
C: 0.9%
KMDA | $5.075 -0.1% -0.1% 6.5K
|
Health Technology
|
| O: 2.31%
H: 1.86%
C: -0.2%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.09%
H: 0.64%
C: -0.45%
business update financial results
Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease
Published: 2023-05-09 (Crawled : 13:00) - globenewswire.com
TCRX 1 d | $6.9 2.22% 2.17% 250K
|
Professional, Scientific, and T...
|
| O: 27.58%
H: 110.1%
C: 18.47%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -3.11%
H: 0.6%
C: -0.14%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.01%
H: 0.34%
C: -0.09%
disease collaboration therapeutics
Zai Lab Announces Full-Year 2022 Financial Results and Recent Corporate Updates
Published: 2023-03-01 (Crawled : 22:00) - globenewswire.com
ZLAB | News | $14.2 3.5% 3.38% 690K
|
Health Technology
|
| O: -9.19%
H: 6.71%
C: 0.71%
DCPH | $14.235 -3.3% -3.41% 760K
|
Health Technology
|
| O: -1.15%
H: 0.82%
C: -0.62%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.03%
H: 0.11%
C: -0.58%
financial results
Entera Bio Announces FDA’s Acceptance of a Type D Meeting Review to Affirm Design of the Pivotal, Phase 3 Protocol for EB613 PTH Mini Tablets, as the First Oral Osteoanabolic Treatment of Post-Menopausal Osteoporosis
Published: 2023-02-15 (Crawled : 15:20) - globenewswire.com
ENTX | $2.25 1.35% 1.33% 170K
|
Health Technology
|
| O: 2.34%
H: 9.2%
C: 8.45%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.34%
H: 0.14%
C: -0.06%
eb613 treatment meeting review osteoporosis
Sandoz Biologics License Application for proposed biosimilar denosumab accepted by US FDA
Published: 2023-02-06 (Crawled : 07:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: -2.93%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.33%
H: 0.15%
C: -0.12%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.08%
H: 0.59%
C: -0.62%
fda biosimilar application license
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.